Focus: Allergy Therapeutics is a UK-based biotech specialist in allergy vaccines and immunotherapies, operating at a mid-cap scale with focus on niche allergy indications. The company occupies a targeted position in the vaccine and infectious disease markets.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Allergy Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Allergy Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Allergy Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Phase 4 program across multiple trial sites indicating mature, commercial-stage influenza vaccine.
Phase 3 allergen immunotherapy candidate directly aligned with company's core allergy vaccine competency.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moSource: USCIS H-1B Employer Data Hub